alcohol glp-1 receptor agonists are promising but unproven treatments for and substance use disorders Small study finds GLP-1 drug

Improving Cognitive Performance IGF-1 LR3 shows great potential for improving cognitive performance, especially in patients with low growth hormone levels, where these symptoms are more common

From here, ribose 5-phosphate can be utilized as a precursor to synthesize various other nucleotides

As an investigational compound, it has not yet received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA), and its use remains confined to clinical research settings

Available online at: 181 YangBHuangJXiangTYinXLuoXLuoFet al

Shame and Stigma Many GLP-1 users carry a private burden: the belief that needing this medicine is proof of something they failed to do on their own